Revolution Medicines (RVMD) Tax Provisions (2020 - 2024)
Revolution Medicines (RVMD) posted Tax Provisions of -$800000.0 for Q4 2024, down 333.24% on a QoQ basis from $343000.0 in Q4 2023, and down 333.24% year-over-year from $343000.0 in Q1 2024.
Powered by 
Analysis
Revolution Medicines (RVMD) Tax Provisions (2020 - 2024) Analysis & Trends
Revolution Medicines has reported Tax Provisions for 4 years, with the latest figure at -$800000.0 in Q4 2024.
- On a quarterly basis, Tax Provisions fell 333.24% year-over-year to -$800000.0 in Q4 2024; TTM through Dec 2024 was -$800000.0, a 77.3% increase from a year earlier, with the FY2025 full-year figure at -$237.6 million, down 29596.62% from the prior year.
- Tax Provisions was -$800000.0 for Q4 2024 at Revolution Medicines, down from $343000.0 in the prior quarter.
- The five-year high for Tax Provisions was $362000.0 in Q4 2020, with the low at -$3.9 million in Q3 2023.
- Average Tax Provisions over 4 years is -$639375.0, with a median of -$210000.0 recorded in 2022.
- The largest YoY upside for Tax Provisions was 378.86% in 2023 against a maximum downside of 1202.02% in 2023.
- Over 4 years, Tax Provisions stood at $362000.0 in 2020, then slumped by 133.98% to -$123000.0 in 2022, then surged by 378.86% to $343000.0 in 2023, then slumped by 333.24% to -$800000.0 in 2024.
- The last three Tax Provisions figures came in at -$800000.0 (Q4 2024), $343000.0 (Q4 2023), and -$3.9 million (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -291.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 393.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 242.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -407.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 292.00 Mn |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -800,000.00 |
| Dec 31, 2023 | 343,000.00 |
| Sep 30, 2023 | -3.87 Mn |
| Dec 31, 2022 | -123,000.00 |
| Sep 30, 2022 | -297,000.00 |
| Dec 31, 2020 | 362,000.00 |
| Jun 30, 2020 | -58,000.00 |
| Mar 31, 2020 | -675,000.00 |
API Access
Revolution Medicines Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();